Modulators of protein secretion

HK40137340APending Publication Date: 2026-09-11SANOFI SA(FR) +3
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
HK62026123969
Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-11
Filing Date
2026-05-26
Publication Date
2026-09-11

Smart Images

  • Figure 00000030_0000
    Figure 00000030_0000
  • Figure 00000031_0000
    Figure 00000031_0000
  • Figure 00000031_0001
    Figure 00000031_0001
Patent Text Reader

Abstract

The present disclosure provides a method for identifying modulators of protein secretion. Also provided are modulators of protein secretion and use thereof.
Need to check novelty before this filing date? Find Prior Art

Description

Abstract This disclosure provides a method for identifying protein secretion regulators. It also provides protein secretion regulators and their uses.

Claims

CLAIMS1. A method of inhibiting protein secretion from a eukaryotic cell, comprising contacting the cell with nigericin or tyrphostin AG-879, or an analog thereof.

2. The method of claim 1, wherein the cell is in a cell culture.

3. The method of claim 2, wherein the contacting comprises adding nigericin, tyrphostin AG-879, or analog to the cell culture.

4. The method of claim 3, wherein the nigericin, tyrphostin AG0879, or analog is added to the cell culture to reach a concentration of about 1 pg / mL to about 100 pg / mL, optionally about 5 pg / mL to about 50 pg / mL.

5. The method of claim 3, wherein the nigericin, tyrphostin AG0879, or analog is added to the cell culture to reach a concentration of at least about 50 pg / mL; optionally, wherein the nigericin, tyrphostin AG0879, or analog is added to the cell culture to reach a concentration of about 50 pg / mL.

6. A method of increasing protein secretion from a eukaryotic cell, comprising contacting the cell with lycorine or an analog thereof.

7. The method of claim 5, wherein the eukaryotic cell is a recombinant cell engineered to express a recombinant protein.

8. The method of claim 6, wherein the recombinant protein is an enzyme for enzyme replacement therapy, or an antibody.

9. The method of any one of claims 5-7, wherein the cell is in a cell culture.

10. The method of claim 8, wherein the contacting comprises adding lycorine or analog to the cell culture.

11. The method of claim 9, wherein the lycorine or analog is added to the cell culture toreach a concentration of about 0.1 pM to about 100 pM, optionally about 1 pM to about 50 pM.

12. The method of claim 9, wherein the lycorine or analog is added to the cell culture to reach a concentration of at least about 1 pM.

13. The method of claim 9, wherein the lycorine or analog is added to the cell culture to reach a concentration of about 1 pM or of about 50 pM.

14. The method of any one of the preceding claims, wherein the eukaryotic cell is a mammalian cell, an insect cell, or a yeast cell.

15. The method of claim 11, wherein the cell is a mammalian cell, optionally a CHO cell, a NS0 cell, a BHK cell, a 293 cell, a HeLa cell, a HEK cell, or a Sp2 / 0 cell.